Skip to content
Search

Latest Stories

GPhC appoints Louise Edwards as new Chief Strategy Officer

GPhC appoints Louise Edwards as new Chief Strategy Officer

Louise will succeed Mark Voce who is taking early retirement from the GPhC’s position in July 2024

The General Pharmaceutical Council (GPhC) has promoted Louise Edwards to the position of Chief Strategy Officer and Deputy Registrar.


Louise is currently the Director of Regulation and Digital Transformation at the Electoral Commission, responsible for the organisation’s regulatory work and digital, data, technology and facilities infrastructure.

This includes funding and spending at elections and referendums, registering political parties, enforcement work, and data and information management.

Louise will take over Mark Voce, the GPhC’s current Chief Strategy Officer and Deputy Registrar, who is retiring early in July 2024.

Louise said: "Pharmacy services are at the heart of health care for many people. Having effective regulation and standards in place can transform and give confidence in the quality of care that people receive.

“I am delighted to be appointed as the new Chief Strategy Officer and Deputy Registrar of the General Pharmaceutical Council, and having the opportunity to deliver its vital work to improve the health and well-being of people using pharmacy services.”

The Chief Strategy Officer is one of the four Chief Officers who share delegated authority from the Chief Executive & Registrar to lead the organisation and provide direction to senior management colleagues.

In her role as Chief Strategy Officer and Deputy Registrar, Louise will oversee the GPhC's strategy, pharmacy education and training, regulation reform, equality, diversity and inclusion, as well as its public affairs and external communication work across all teams. She will ensure these collectively follow a single strategic approach.

Duncan Rudkin, GPhC Chief Executive, said: “Our Chief Strategy Officer plays an absolutely critical role in delivering our vision and objectives. I am delighted that Louise will be taking on the role when she joins us in July, and I look forward to working closely with her.”

Duncan also paid tribute to Mark for “the enormous contribution he has made to pharmacy regulation” during his time in this role, and in his previous roles as Director of Education and Standards, and Head of Inspection.

“Mark’s achievements include leading our programme of work to transform the education and training of pharmacists and pharmacy technicians, both before and after registration.

“Mark has worked closely and effectively with stakeholders across Great Britain to introduce once-in-a-generation reforms which will mean that from 2026, all newly qualified pharmacists will be independent prescribers when they join the register,” he added.

According to Duncan, Louise will continue Mark's work to ensure that the regulation of the education and training of pharmacists and pharmacy technicians is strategically designed, implemented and developed to deliver on the vision agreed by the Council.

Louise will also oversee the development and evaluation of GPhC’s next five-year strategic plan, aimed at realising its vision for safe and effective pharmacy care at the heart of healthier communities.

Prior to joining the Electoral Commission, Louise worked for a range of regulators including the Charity Commission for England and Wales, The Independent Parliamentary Standards Authority, Ofgem and the Home Office.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less